Nimodipine is a dihydropyridine calcium channel blocker used in research models involving cerebral vasospasm, subarachnoid hemorrhage, and neuroprotection. It selectively inhibits calcium influx into vascular smooth muscle, particularly in the brain.

This product contains 4mg of nimodipine per 20ml ampoule, packaged as 5 ampoules per box, manufactured by Furen Pharmaceutical Group Co., Ltd. Approved by China NMPA with license number H20068125 and product code 86903010000674.

?? For laboratory research use only. Not for human or veterinary administration.

Product Specifications

Mechanism of Action & Research Applications

Nimodipine blocks L-type calcium channels in smooth muscle cells, reducing vasoconstriction, especially in cerebral arteries. It has high lipophilicity, allowing penetration across the blood-brain barrier, making it ideal for neurological and cerebrovascular research.

Research Applications Include:

• Cerebral ischemia and infarction models

• Subarachnoid hemorrhage-induced vasospasm

• Neuroprotective pharmacology

• Blood-brain barrier permeability studies

• Calcium channel modulation research

Observed Side Effects (in Lab Models)

In preclinical studies, side effects observed at high doses may include:

• Hypotension

• Bradycardia

• Dizziness or sedation

• Local irritation at the injection site

Handling & Safety Information

Intended Use: Laboratory research only
Personal Protective Equipment: Gloves, lab coat, eye protection
Storage: Below 25°C, shield from light and moisture
Disposal: Dispose of in accordance with local chemical safety protocols

Research Use Disclaimer

This product is intended exclusively for scientific research purposes. It is not approved for human, veterinary, or diagnostic use. Misuse may lead to regulatory or safety violations. Handle with standard laboratory safety protocols.